Mijeong Park

Mijeong Park

Auto-generated profile, based on publicly available information

Mijeong Park

Mechanisms of Disease and Translational Research, School of Biomedical Sciences, Faculty of Medicine & Health, University of NSW, Sydney, NSW, 2052, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Stem Cell Reports
Verified
Journal Article
Open access
MPMijeong Park
Mijeong Park
ARAlexander Richardson
Alexander Richardson
EPElvis Pandzic
Elvis Pandzic
ELErwin P. Lobo
Erwin P. Lobo
RWRenee Whan
Renee Whan
NGNick Di Girolamo
Nick Di Girolamo
It is thought that corneal epithelial injuries resolve by leading-edge cells "sliding" or "rolling" into the wound bed. Here, we challenge this notion and show by real-time imaging that corneal wounds initially heal by "basal cell migration." The K14CreERT2-Confetti multi-colored reporter mouse was employed to spatially and temporally fate-map cellular behavior during corneal wound healing. Keratin-14+ basal epithelia are forced into the wound bed by increased population pressure gradient from the limbus to the wound edge. As the defect resolves, centripetally migrating epithelia decelerate and replication in the periphery is reduced. With time, keratin-14+-derived clones diminish in number concomitant with their expansion, indicative that clonal evolution aligns with neutral drifting. These findings have important implications for the involvement of stem cells in acute tissue regeneration, in key sensory tissues such as the cornea.

16 December 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MPMijeong Park
Mijeong Park
ARAlexander Richardson
Alexander Richardson
EPElvis Pandzic
Elvis Pandzic
ELErwin P. Lobo
Erwin P. Lobo
JLJ. Guy Lyons
J. Guy Lyons
NGNick Di Girolamo
Nick Di Girolamo
Significance: The well-accepted proposition that central corneal epithelia have limited self-renewal and therefore poor regenerative capacity has recently been challenged. However, methods for real-time monitoring to identify which cells take part in this process are scant. In this study, we visualized and quantified the contribution of central versus peripheral/limbal epithelia during annular wound healing by intravital imaging, through an organ culture system, and via computational modeling. Our results verify the contribution of K14 + limbal-derived stem cells and their early progeny in playing a vital role in this process, while central corneal epithelia contribute minimally to wound closure.

4 September 2023 in Advanced Functional Materials
Verified
Journal Article
Open access
MPMijeong Park
Mijeong Park
ARAlex Richardson
Alex Richardson
NDNaomi Delic
Naomi Delic
KNKim Nguyen
Kim Nguyen
JBJoanna Biazik
Joanna Biazik
NGNick Di Girolamo
Nick Di Girolamo
Limbal stem cell deficiency (LSCD) is characterized by the loss of limbal epithelial stem cells (LESCs) which compromises corneal transparency, leading to blindness. It cannot be treated with pharmacological or corneal transplantation interventions, instead a specialized stem cell (SC) therapy is needed to restore eye health and sight. Herein, a native cornea‐derived biomaterial, a by‐product of a laser refractive surgical procedure called small incision lenticule extraction is identified as a new cell delivery matrix. Culture conditions are optimized to facilitate LESC attachment, expansion and stratification, and their identity is immunophenotyped. Using electron microscopy, bio‐constructs display stratification, similar to the architectural and cellular organization of a native mammalian cornea with formation of a basement membrane and an orderly array of collagen fibrils. Neuronal growth and depleted CD45+/CD14+ leukocytes on lenticules are also shown, suggesting that in transplantation experiments, they will re‐innervate and not trigger a host‐mediated immune response. Finally, human lenticules are geometrically customized to successfully fit them over a LSCD murine cornea ex vivo, during which they maintain curvature. The authors are poised to conduced similar studies in live mice using these and other carriers currently used in the clinic to compare SC therapy outcomes.

28 November 2025 in The Ocular Surface
Verified
Journal Article
Open access
MPMijeong Park
Mijeong Park
EPElvis Pandzic
Elvis Pandzic
JMJohn Males
John Males
NGNick Di Girolamo
Nick Di Girolamo
Disease that develops on the ocular surface in animals and humans that have their limbal stem cells erased or their niche severely damaged by physical or chemical trauma, is difficult to visually evaluate in a progressive and long-term manner. When limbal stem cell deficiency (LSCD) develops under such circumstances, intravital clinical microscopy or other techniques cannot be used to accurately detail what transpires on the cornea. Here, we investigated the evolution of LSCD and characterize cellular transformations that arise when the limbal niche is lost. We employed the multi-color K14CreERT2-Confetti transgenic reporter mice (n = 51) to monitor LSCD in real-time, combined with proliferation markers and in vitro analyses to identify and characterize conjunctival epithelial transformations using wild-type C57BL/6 mice (n = 31). Conjunctival epithelia either spawn MUC5AC + goblet cells (GCs) or K12+ cornea-like epithelia. These cells arise from Ki67+ proliferating differentiated conjunctival squames as opposed to DNA label retaining conjunctival stem/progenitor cells. In vitro analyses suggests that GC metaplasia (GCM) and conjunctival transdifferentiation (CjTD) evolve from environmental stress and soluble keratocyte elaborated signals and corneal matrix-associated physical cues. GCM is a pathological process, as opposed to CjTD, which is the cornea's attempt to self-repair. The co-existence of two fundamentally diverse cellular interchanges establishes a medical conundrum in LSCD which may be resolved via pharmacological or biological intervention in conjunction with surgery to replenish the stem cell pool.